ORCHARD PARK, N.Y., Nov. 8, 2017 /PRNewswire/ -- Oncotarget, the world's largest oncology peer-reviewed research publication, is set to extend
Subscribers to the new podcast series will gain access to the journal's most important discoveries through full readings of published papers, interviews with outstanding authors, and selected readings from the Oncotarget blog. The podcast will highlight topics in oncology and beyond, including aging, pathology, immunology and microbiology, autophagy, chromosome, neuroscience, endocrinology, cardiology, metabolism, cell biology, pharmacology and more on Stitcher, Blubrry, and Soundcloud.
"Our mission has always been to make exceptional discoveries rapidly and widely available, eliminate borders between specialties by linking different fields of biomedical science and foster applications of basic and clinical science," said Mikhail Blagosklonny, Oncotarget's editor-in-chief. "This new podcast series will be another way to deliver people free access to the research published in this journal."
The podcast series will contain multiple streams that will target a variety of listeners.
In addition to providing an additional free service to its readers, the podcast benefits the publication's authors as they seek to communicate their findings and disseminate their research to pertinent stakeholders.
"Oncotarget does not stop once the paper is published," said Blagosklonny. "It is only halfway done. This podcast is part of an enhanced post publication service Oncotarget provides to authors of its papers by helping them to reach a wider audience." This service includes publicizing the research on Oncotarget's homepage, its social platforms, and via its other public relations efforts.
Don't miss a single episode - subscribe to the Oncotarget podcast via Stitcher, blubrry, and Soundcloud.
About OncotargetOncotarget is twice-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology and publishing sub-sections on topics beyond oncology such as Aging, Immunology and Microbiology, Autophagy, Pathology and Chromosomes and more. Oncotarget is published by Rapamycin Press, the publishing division of Impact Journals LLC.
Media Contact Information:Ryan James JessupRapamycin Press+1 202 638 9720RyanJamesJessup@RapamycinPress.com
View original content:http://www.prnewswire.com/news-releases/new-oncotarget-podcast-launched-today-300552252.html
Subscribe to our Free Newsletters!
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...View All